腫瘍抑制剤DACT3は,Wnt/β-catenin経路を阻害することによって,アパチニブに対するトリプルネガティブ乳がんを感知させる
1Department of Breast Center, Chongqing Key Laboratory for Intelligent Oncology in Breast Cancer (iCQBC), Chongqing University Cancer Hospital, Chongqing 400030, China.
Translational oncology
|August 29, 2025
まとめ
甲酸ベタカテニン3 (DACT3) の分離結合アンタゴニストは,転移性三重陰性乳がん (TNBC) のアパチニブ感受性のバイオマーカーである. DACT3はWnt/β-カテニンのシグナル伝達を阻害することでアパチニブの有効性を高め,TNBCの新たな治療標的となる.
科学分野:
- 腫瘍学
- 分子生物学
- 癌 研究
背景:
- VEGFR2阻害剤であるアパチニブは,転移性三重陰性乳がん (TNBC) で抗腫瘍活性を示しています.
- アパチニブに対する患者の反応は様々であり,個別化された治療と耐性メカニズムの研究のためのバイオマーカーが必要である.
- 耐性を理解することはTNBCの新たな治療戦略の開発に不可欠です.
研究 の 目的:
- TNBCにおけるアパチニブ感受性のバイオマーカーを特定する.
- アパチニブ耐性の原因を調査する.
- アパチニブの有効性を高めるための潜在的な治療標的としてDACT3を調査する.
主な方法:
- DACT3を患者の発現分析によって感受性のバイオマーカーとして特定する.
- TNBC細胞系 (MDA-MB231,YCCB1) でのDACT3の外体発現
- アパチニブIC50値とWnt/β-カテニンのシグナル伝達経路の抑制の評価
主要な成果:
- アパチニブに敏感なTNBC患者では,DACT3発現が著しく高く,生存期間が長くなることが相関する.
- MDA- MB231およびYCCB1細胞におけるアパチニブIC50の外因的なDACT3発現が減少した (それぞれ16. 04μMから8. 81μM,および19. 65μMから9. 42μM).
- DACT3はWnt/β-カテニンのシグナル伝達を阻害し,アパチニブに対する耐性を克服するメカニズムを示唆する.
結論:
- DACT3は,TNBCにおけるアパチニブ反応の潜在的予測バイオマーカーとして機能する.
- DACT3はアパチニブに対するTNBCの感受性を改善する新しい治療目標です.
- DACT3によるWnt/β-cateninシグナル伝達の抑制は,アパチニブの有効性を高め,耐性を克服する鍵となる.
関連する概念動画
Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
The Intrinsic Apoptotic Pathway
6.8K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.8K
Inhibition of Cdk Activity
4.9K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.9K
PI3K/mTOR/AKT Signaling Pathway
3.9K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.9K
Canonical Wnt Signaling Pathway
8.9K
The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which...
8.9K
Non-Canonical Wnt Signaling Pathways
7.4K
Wnt is a zygotic effect gene that is expressed during very early embryonic development. It regulates various processes in animals starting from early development through the adult stage, such as organogenesis in the embryo and maintenance of neuronal and blood stem cells. Wnt proteins can induce a wide variety of intracellular pathways depending upon the specific abilities of different Wnt ligands to form a complex with shared and cognate receptors in the presence of different co-receptors. The...
7.4K


